Back
Corporate News
Norris Medicines to review quarterly results at August board meeting in Ankleshwar
08-Aug-2026, 03:43
Norris Medicines Limited will hold a board meeting on August 14, 2026, at its registered office in Ankleshwar, Gujarat, to approve the unaudited financial results for the quarter ended June 30, 2026, and to address other business matters, according to a regulatory filing with the BSE Limited. The company has also closed its trading window for securities from July 1, 2026, until 48 hours after the unaudited financial results are announced.
Norris Medicines Limited will hold a board meeting on August 14, 2026, at its registered office in Ankleshwar, Gujarat, to approve the unaudited financial results for the quarter ended June 30, 2026, and to address other business matters, according to a regulatory filing with the BSE Limited. The company has also closed its trading window for securities from July 1, 2026, until 48 hours after the unaudited financial results are announced.